Comparison of programmed death-ligand 1 (PD-L1) immunostain for nonsmall cell lung carcinoma between paired cytological and surgical specimens

BACKGROUND: programmed death-ligand 1 (PD-L1) is a ligand for the inhibitory programmed cell death protein 1 (PD-L1), which are targeted by several anti-PD-1 and PD-L1 drugs for lung cancer treatment. In clinical practice, many lung cancer cases only have cytology samples available to test PD-L1. Ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Huihong, Bratton, Laura, Nead, Michael, Russell, Donna, Zhou, Zhongren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319045/
https://www.ncbi.nlm.nih.gov/pubmed/30662515
http://dx.doi.org/10.4103/cytojournal.cytojournal_2_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319045/
https://www.ncbi.nlm.nih.gov/pubmed/30662515
http://dx.doi.org/10.4103/cytojournal.cytojournal_2_18

Ejemplares similares